Assembly of Hepatitis Delta Virus Particles: Package of Multimeric Hepatitis Delta Virus Genomic RNA and Role of Phosphorylation  by Yeh, Tien-Shun & Lee, Yan-Hwa Wu
Assembly of Hepatitis Delta Virus Particles: Package of Multimeric Hepatitis
Delta Virus Genomic RNA and Role of Phosphorylation
Tien-Shun Yeh and Yan-Hwa Wu Lee1
Institute of Biochemistry, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan, Republic of China
Received November 24, 1997; returned to author for revision December 31, 1997; accepted June 25, 1998
We previously demonstrated that both casein kinase II (CKII) and protein kinase C (PKC) positively modulate the hepatitis
delta virus (HDV) RNA replication but not the assembly of the empty hepatitis delta antigen (HDAg) particle. In this study, we
investigated whether phosphorylation of HDAg by these two kinases plays a role in assembly of the HDV virion. As
demonstrated by in vivo labeling and kinase inhibitor experiments, the phosphorylation level of large HDAg but not small
HDAg in HDAg-expressing HuH-7 cells was diminished by CKII inhibitor (DRB), whereas no effect was observed for the
phosphorylation level of two HDAgs when treated with protein kinase A (PKA) inhibitor (HA1004) or PKC inhibitor (H7).
Cotransfection experiment also demonstrated that packaging of HDV genomic RNA was not affected by the kinase inhibitor
DRB or H7 and mutation at the putative CKII phosphorylation sites (serine-2, serine-123, or both), and the putative PKC site
(serine-210) of HDAg did not elicit any significant effect on the HDV virion assembly. Therefore, based on the previous work
and the present study, it seems that the status and biological significance of phosphorylation of HDAg vary depending on the
HDV life cycle. Although in the HDV RNA replication cycle, phosphorylation of small HDAg by CKII or PKC plays important
role in HDV replication, phosphorylation of the same HDAg by these two kinases does not occur during the HDV RNA virion
assembly, and phosphorylation of the large HDAg by CKII does not confer any regulatory role in the assembly of HDV virion
and empty viral particles. Our study also showed that the large HDAg without the small HDAg could efficiently assemble both
monomeric and dimeric HDV genomic RNAs into secreted HBV-enveloped virus-like particles. Increasing the transfected
small HDAg-expressing plasmid led to an enhancement of the packaging efficiency for the monomeric HDV genomic RNA
with little effect on the packaging of dimeric HDV RNA. Similarly, HDAgs could package the trimeric HDV genomic RNA, albeit
less efficiently. CsCl density gradient centrifugation confirmed that HDAgs and the monomeric and multimeric (dimer and
trimer) HDV genomic RNAs formed an HBV-enveloped virus-like particle at a density of 1.23–1.25 g/ml. Thus, the assembly
of the HDV virion seems to not impose much restriction on the size of HDV RNA for packaging. © 1998 Academic Press
INTRODUCTION
Hepatitis delta virus (HDV) contains a 1.7-kb single-
stranded circular RNA genome, delta antigen (HDAg),
and a surrounding lipid envelope embedded with hepa-
titis B virus (HBV) surface antigen proteins (HBsAg)
(Rizzetto, 1983; Bonino et al., 1984; Wang et al., 1986,
1987; Makino et al., 1987; Kuo et al., 1988). HDAg is
encoded by an antigenomic strand of HDV RNA and
exists as two protein species: a small 24-kDa form and a
large 27-kDa form (Wang et al., 1986, 1987; Makino et al.,
1987; Kuo et al., 1988). The large HDAg contains the
entire small HDAg open reading frame (ORF) plus 19
additional amino acids at the carboxyl terminus. This
carboxyl-terminal 19-amino-acid extension in the large
HDAg is generated by an RNA editing event during the
process of HDV replication (Weiner et al., 1988; Luo et al.,
1990). These two isoforms of HDAg have opposing bio-
logical functions. Although the small HDAg is required
for genome replication (Kuo et al., 1989), the large HDAg
inhibits HDV RNA replication and is required for HDV
assembly (Chao et al., 1990; Chang et al., 1991; Glenn
and White, 1991; Ryu et al., 1992). It has also been noted
that the formation of HDV viral particles requires the
isoprenylation and specific amino acid sequence at the
carboxyl-terminal of the large HDAg (Glenn et al., 1992;
Lee et al., 1994, 1995). Moreover, studies on the role of
HBV envelope proteins in the assembly of HDV particles
have indicated that although the small HBsAg is suffi-
cient for assembly of the HDV virion, the large HBsAg is
necessary for infectivity of the virion (Ryu et al., 1992;
Sureau et al., 1993; Wang et al., 1991).
The HDAg has multiple functional domains, which is
relevant to their biological properties, such as oligomer-
ization, RNA-binding ability, and nuclear transport (for
reviews, see Lazinski and Taylor, 1993; Lai, 1995 and
references therein). The two forms of the HDAg bind to
HDV RNA with equal affinity, forming a ribonucleoprotein
particle (RNP), and they recognize the truncated HDV
RNA, which is capable of folding into a rod-like structure
(Chang et al., 1988, 1995; Lin et al., 1990; Chao et al.,
1991; Ryu et al., 1993; Lazinski and Taylor, 1994). Notably,
previous studies have also indicated that the large HDAg
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alone is capable of packaging monomeric HDV genomic
RNA into virus particles, whereas the incorporation of
small HDAg increases the HDV RNA packaging effi-
ciency (Wang et al., 1994).
Both HDAgs have been detected as nuclear phospho-
proteins (Chang et al., 1988; Hwang et al., 1992; Yeh et al.,
1996), although certain data suggest that the large HDAg
but not the small HDAg is phosphorylated (Bichko et al.,
1997). Because it is well known that phosphorylation
can regulate the activities of protein at multiple levels,
including nuclear transport, dimerization, nucleic acid bind-
ing, and transcriptional activation (Hunter and Karin, 1992),
similarly, phosphorylation may affect these properties of
the HDAg. We previously investigated the functional role
of HDAg phosphorylation in HDV RNA replication, packag-
ing, and nuclear transport (Yeh et al., 1996). Our results
suggest that although phosphorylation of serine-2 by ca-
sein kinase II (CKII) is important for the replication function
of small HDAg, phosphorylation of three conservative
serine residues (serine-2, serine-123, and serine-210) by
CKII or protein kinase C (PKC) seems functionally irrelevant
to the assembly of the empty viral particle or in the trans-
dominant inhibitory activity of large HDAg on HDV replica-
tion (Yeh et al., 1996). Furthermore, they are not a prereq-
uisite for either form of HDAg entrance into the nucleus.
The remaining issue of whether phosphorylation of these
serines plays a role in the RNA-binding ability during the
virion assembly is addressed in this study. Interestingly, we
found that contrary to HDV RNA replication, phosphoryla-
tion by both CKII and PKC does not elicit any effect on the
HDV RNA package. Moreover, we demonstrate here that
HDAgs together with HBsAg can assemble the multimeric
(dimer and trimer) form of HDV RNA with almost indistin-
guishable property as the HDV virion-containing mono-
meric form of HDV genomic RNA.
RESULTS
HDAgs are capable of copackaging the dimeric form
of HDV RNA in the presence of HBsAg
To investigate the role of phosphorylation of HDAgs in
HDV RNA packaging in vitro without the complication
generated from RNA replication, we adapted the four-
plasmid cotransfection system developed by Wang et al.
(1994). In this system, each component of the HDV virion
was supplied by an individual plasmid, including the
expression plasmids for the HBsAg (pMTS), the large
HDAg (pECE-D), the small HDAg (pECE-d), and the HDV
RNA template (pCDm2G). The latter construct pCDm2G
contains a tandem dimer of the full-length, mutated HDV
cDNA harboring a frameshift mutation that prevents the
production of both species of HDAg (Wang et al., 1994).
This plasmid presumably can supply the HDV genomic
RNA for assay of the HDV genome package by cotrans-
fecting with the expression constructs of both HDAgs
and HBsAg (Wang et al., 1994). To assess the feasibility
of this system for assay of HDV virion assembly, HDAgs
and HDV RNAs from within cells (cellular), as well as
those secreted in the presence of HBsAg (medium) after
day 3 post-transfection, were evaluated by immunoblot-
ting and Northern blotting. As demonstrated in Figure 1A,
in HuH-7 cells transfected with plasmid pCDm2G, the
intracellular 3.4-kb primary HDV transcript could undergo
self-processing to generate a full-length, monomeric
HDV RNA (Fig. 1A, lane 2). However, without the small
HDAg expression, this mutant HDV RNA could not rep-
licate because no antigenomic HDV RNA was found (Fig.
1A, lane 2 in cellular G RNA and AG RNA sections). If
HuH-7 cells were cotransfected with four plasmids under
the conditions in which the amounts of transfected plas-
mids for HBsAg and pCDm2G were fixed (20 mg each)
FIG. 1. Analysis of HDV RNA package after the cotransfection. HuH-7 cells were cotransfected with a plasmid expressing the mutant HDV RNA
(pCDm2G) (20 mg), a plasmid expressing HBsAg (pMTS) (20 mg), and a plasmid expressing large HDAg (pECE-D, designated DWT) or small HDAg
(pECE-d, designated dWT) at the indicated amounts. Total cellular RNA (A) and the RNA of viral particles (B) from day 3 post-transfected cells were
prepared and analyzed by Northern blotting using HDV strand-specific riboprobe (see Materials and Methods). The intracellular (A) and secreted
HDAgs (B) were detected by Western blotting using a human anti-HDAg antibody (see Materials and Methods). The positions for the monomeric or
dimeric HDV RNA, as well as the positions for the large (L) or small HDAg (S), are indicated. (M) Mock without transfection. (G RNA) Genomic HDV
RNA. (AG RNA) Antigenomic HDV RNA.
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but varying the plasmid ratio for the small to large HDAg,
results from Northern blot analysis indicated that both
forms of HDAgs could enhance the yield and the ratio of
monomeric to dimeric HDV genomic RNAs compared
with that without the HDAg-expressing plasmid (Fig. 1A,
compare lane 2 with lanes 3–7 in cellular G RNA). This
suggested that the HDAg could stabilize the HDV RNA
and enhance the ribozyme activity as well, which is in
accord with previous reports (Lazinski and Taylor, 1994;
Jeng et al., 1996). It is also noted that the ratio of intra-
cellular monomeric to the dimeric HDV RNA varied de-
pending on the different combination of both forms of
HDAg introduced. In particular, the dimeric HDV RNA
was present predominantly if the transfected small
HDAg-expressing plasmid was excluded or the trans-
fected large HDAg-expressing plasmid was in great ex-
cess compared with the small HDAg-expressing plasmid
(Fig. 1A, lanes 4 and 7 in cellular G RNA). However, as
judged by the presence or lack of antigenomic RNA, it
appears that as long as the large HDAg-expressing plas-
mids are present in equal (lane 6) or excess (lanes 4 and
7) amount compared with the small HDAg, no detectable
HDV replication occurred.
When examining the secreted HDV-like particle, in the
absence of large HDAg expression, no HDV-like particle
was secreted in the culture medium (Fig. 1B, lane 3). This
result supports the essential role of large HDAg in HDV
viral particle assembly as previously noted elsewhere
(Chang et al., 1991). Interestingly, exclusion of the small
HDAg expression plasmid while leaving the cells trans-
fected with only the large HDAg expression plasmid and
the other two plasmids (pCDm2G and pMTS) could lead
to a copackage of the large HDAg with HDV RNA in the
culture medium (Fig. 1B, lane 4). A similar observation
was reported by other investigators (Wang et al., 1994).
However, it should be noted that in this particular exper-
iment, both the dimeric and monomeric forms of HDV
RNAs were packaged into the HDV viral particle with
almost equal efficiency (Fig. 1B, lane 4). Increasing the
transfected small HDAg plasmid from 2 to 20 mg (small-
to-large HDAg plasmid ratio, 2:20 or 20:20; lanes 6 and 7)
or increasing the plasmid ratio of transfected small
HDAg to large HDAg (20:2 ratio; lane 5), however, re-
sulted in a significant increase in the packaging of the
monomeric form of HDV RNA, which is consistent with a
previous report (Wang et al., 1994). The amount of
dimeric HDV RNA packaged into the virus-like particle
was largely unaltered except in the transfected cells
containing equal amounts (20 mg each) of transfected
large and small HDAg plasmids, whereas a slight in-
crease in secreted dimeric form of HDV RNA was noted
(Fig. 1B, lane 6). These results reveal that the large HDAg
could package the HDV dimeric RNA independent of the
small HDAg. On the contrary, the packaging efficiency of
the monomeric form of HDV RNA was highly dependent
on introduction of the small HDAg into the transfection
experiment.
Characterization of HDV virus-like particles containing
the multimeric form of HDV RNA
To further demonstrate that multimeric HDV RNAs
were actually packaged into virus-like particles, HuH-7
cells were cotransfected with 20 mg each of four plas-
mids. In this series of experiments, the HDV RNA tem-
plates for package were provided by construct pCDm2G
or pCDm3G. The construct pCDm3G contains a mutated
tandem trimer of HDV cDNA; therefore, it can yield the
unprocessed trimeric and self-processed dimeric or mo-
nomeric forms of genomic HDV RNAs in the HuH-7 cell
line but in varying amounts (Fig. 2A, lane 3). Like the
dimeric HDV genomic RNA, the trimeric one also was
packaged into the virus particle (Fig. 2B, lanes 2 and 3).
To test whether these virus-like particles with multimeric
HDV RNA contain the HBsAg as its envelope, the virus
particles collected from day 3 post-transfection were
immunoprecipitated with mouse anti-HBsAg monoclonal
antibody, and the immunoprecipitates were analyzed by
Northern blotting using the HDV antigenomic RNA as a
probe. Results suggest that all the trimeric, dimeric, and
monomeric forms of HDV RNAs can form a virus-like
particle with HBV envelope protein (Fig. 2C, lanes 2 and
3). This RNA-packaging activity by HDAgs was rather
sequence specific because no package of abundant
cellular RNA such as 18S rRNA was detected in the
HBsAg-enveloped particle (Fig. 2D, lanes 2 and 3). CsCl
gradient centrifugation was then performed to determine
the density of the viral particle containing the multimeric
forms of HDV RNAs. When the construct pCDm2G was
used to express HDV RNA template for package, both the
dimeric and monomeric HDV RNAs were banded to-
gether in fractions 13–15 (Fig. 3A). These fractions had a
density of 1.23–1.25 g/ml, which is similar to the density
of the HDV virion reported by others (Chang et al., 1991;
Wang et al., 1994). Notably, the peak fractions for HBsAg
appeared at fraction 12, which corresponded to a density
of empty virus-like particle at 1.21 g/ml. Similarly, when
the HDV RNA template for the package was provided by
the construct pCDm3G, all three sizes of HDV RNAs were
also banded together in a fraction with a density of 1.24
g/ml (Fig. 3B). These studies demonstrated that all the
trimeric, dimeric, and monomeric HDV RNAs were in-
deed packaged into viral particles with a density distinct
from that of empty particles.
Inhibitors of CKII and PKC do not affect the assembly
and secretion of the HDV viral particle
Our previous studies have shown that both CKII and
PKC positively modulate the HDV RNA replication but not
the assembly of the empty HDAg particle (Yeh et al.,
1996). Here, we investigated whether phosphorylation of
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HDAg by these two kinases plays a role in HDV virion
assembly. When examined for the in vivo phosphoryla-
tion of both forms of HDAg in HuH-7 cells transiently
transfected with the HDAg expression construct, our
results suggested that the CKII inhibitor (DRB) could
block the phosphorylation intensity (50% reduction) of
large HDAg but not that of the small HDAg (Fig. 4,
compare lane 2 with lane 3 and lane 6 with lane 7).
Interestingly, both PKC and PKA inhibitors, H7 and
HA1004, did not elicit any apparent effect on the phos-
phorylation intensity of two HDAgs (Fig. 4, compare
lanes 4 and 5 with lane 2 and lanes 8 and 9 with lane 6).
Next, we examined the effect of kinase inhibitor on the
HDV virion assembly. To this end, HuH-7 cells cotrans-
fected with HDV dimeric cDNA plasmid (pCDm2G) and
the expression constructs for the large HDAg (pECE-D),
small HDAg (pECE-d), and HBsAg were treated with the
kinase inhibitor. As shown in Figure 5, on treatment with
DRB or H7, the same level of HDAgs was detected in
both the intracellular and extracellular fractions of the
control and inhibitor-treated cells. Furthermore, the lev-
els of dimeric and monomeric forms of HDV genomic
RNA present in the intracellular and extracellular frac-
tions of the treated cells, as detected by the strand-
specific riboprobe, were similar to those of transfected
cells without the inhibitor treatment. Apparently, these
two kinase inhibitors do not exert any significant inhibi-
tion of HDV RNA packaging.
Mutation at serine-2, serine-123, or serine-210 of the
HDAgs does not block the HDV viral RNA package
According to our previous study, serine-2, serine-123,
and serine-210 are the three most conserved serine
residues among HDAg variants; they also are the recog-
nition sites for CKII or PKC kinases (Yeh et al., 1996). To
further examine whether phosphorylation of serine-2,
serine-123, or serine-210 residues in two species of
HDAg is required for the formation of the virus-like par-
ticle, the wild-type, or mutant form, of the HDAg expres-
sion construct harboring serine-to-alanine substitution
mutation at these three serine residues, together with
the HBsAg expression construct and HDV cDNA plasmid
pCDm2G, were cotransfected into HuH-7 cells. Analysis
of the secreted HDV viral particles by immunoblotting
and Northern blotting indicated that all HDAg mutant
variants, including the double mutant harboring substi-
tution mutations at both serine-2 and serine-123, essen-
tially retained the wild-type ability for the formation of
HDV viral particles (Fig. 6). Thus, phosphorylation of
HDAg at serine-2, serine-123, and serine-210 by CKII or
PKC, if it occurs in vivo, does not appear to play any
significant role in HDV viral RNA particle assembly. This
result is consistent with the finding obtained from the
inhibitor experiment (Fig. 5) and further confirms that
PKC and CKII kinases are not involved in the assembly of
HDV RNA particle.
DISCUSSION
Our previous studies demonstrated that CKII and PKC
modulate the HDV RNA replication but not the assembly
of the empty viral particle. To further assess whether CKII
and PKC regulate the package of HDAg for HDV RNA
without the complication of HDV RNA replication, we
adopted the four-plasmid cotransfection experiment
(Wang et al., 1994) to address this question. In this
system, the HDV RNA for the virion package was pro-
vided by the construct pCDm2G or pCDm3G, and the
amounts of the large and small forms of HDAg-
FIG. 2. Northern blot analysis of HDV virion RNA after immunoprecipitation with anti-HBsAg antibody. HuH-7 cells were cotransfected with the equal
amounts (20 mg each) of four plasmids: pECE-D, pECE-d, pMTS, and pCDm2G (lane 2) or pCDm3G (lane 3). At day 3 post-transfection, virions were
prepared from the culture medium (B) and immunoprecipitated with anti-HBsAg antibody (C and D). Cellular RNA (A and D, lane 4) and viral RNA (B–D)
were prepared and analyzed by Northern blotting using HDV strand-specific riboprobe (B and C) or using the cDNA fragment of 18S rRNA as a probe
(D) (see Materials and Methods). (Lane 1) Mock without transfection. [Lane 4 (D)] Sample from the cellular RNA to serve the positive control. The
positions for the trimeric, dimeric, or monomeric HDV RNA are indicated.
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expressing plasmid transfected under these conditions
(20 mg each) were such that no HDV RNA replication was
allowed (see Fig. 1A). On the basis of in vivo labeling and
kinase inhibitor treatment experiments, we have three
lines of evidence to support that phosphorylation of
HDAg does not confer any regulatory role in the HDV
virion assembly. (1) Neither HDAgs is the in vivo sub-
strate for PKC and PKA. (2) Although the phosphorylation
intensity of large HDAg was diminished by the CKII
inhibitor, the assembly of HDV virion was not affected by
the inhibitors of CKII and PKC. (3) Mutation of HDAg at
the putative CKII or PKC recognition sites does not influ-
ence the packaging of HDV viral particles. Therefore,
based on this work and our previous studies (Yeh et al.,
1996), it appears that the phosphorylation status of the
small HDAg varies depending on the HDV life cycle. In its
RNA replication cycle, the phosphorylation of the small
HDAg in the CKII or PKC recognition site occurs and
plays an important role in regulation of the HDV RNA
replication process (Yeh et al., 1996). Nevertheless, phos-
phorylation of the same antigen by these two kinases
apparently does not occur during packaging of both HDV
virion and its empty virus-like particle (Yeh et al., 1996;
present work). Intriguingly, phosphorylation of the large
HDAg seems dispensable to any of its function known so
far (e.g., trans-dominant function, viral and empty particle
assembly, nuclear transport) (Yeh et al., 1996; present
work). This implies that phosphorylation probably does
not affect the oligomerization or the RNA-binding affinity
of the HDAg, which presumably are important for assem-
bly of HDV virion.
Our finding that HDAgs could package the dimeric or
FIG. 3. CsCl density gradient analysis of HDV viral particles. (A) HuH-7 cells were cotransfected with equal amounts (20 mg each) of plasmid
pECE-D, pECE-d, pCDm2G, and HBsAg construct pMTS. (B) pCDm3G instead of pCDm2G was used to express the HDV RNA. At day 3
post-transfection, virions were prepared from the culture medium and subjected to isopycnic centrifugation in a CsCl gradient (see Materials and
Methods). (Top) Density profile of each fraction. Each fraction was analyzed for HDV genomic RNA by Northern blotting using HDV strand-specific
riboprobe and for HDAg or HBsAg (expressed as P:N ratio) by Western blotting or EIA. All symbols are similar to those described in the legend for
Figure 1 or 2.
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trimeric form of HDV RNA into the virus-like particles was
rather surprising because in a similar system, no such
phenomenon was found (Wang et al., 1994). Although the
exact basis for the cause of this phenomenon remains
unclear, there are several possible explanations. The
amount of DNA used for transfection as well as the
transfection efficiency may contribute to this discrep-
ancy. Nevertheless, the question arises of whether the
monomeric and dimeric HDV RNAs can be copackaged
into the same virus particle. Although we have evidence
to show that the viral particle with multimeric form of
HDV RNA has the same buoyant density as that of
monomeric one and forms an envelope with HBsAg and
HDAgs, this does not provide direct evidence to support
the notion that these two forms of HDV RNA are copack-
aged into the same particle. Despite this limitation, it is
reasonable to envision that the size of virion with multi-
meric HDV RNA may be larger than the one packed with
the monomeric HDV RNA. If this is the case, it is of
relevance to know whether there is any large size limi-
tation for package of HDV RNA. When considering that
the truncated HDV genomic RNA with a rod-like structure
but a size of ,350 nucleotides is competent for packag-
ing into RNP particles (Lazinski and Taylor, 1994), it
seems that the rod-like structure but not the size of HDV
RNA governs the assembly of HDV virion by the HDAg.
Further examination of the capability of HDAg to assem-
ble the larger size (more than trimer) of HDV RNA may
verify this viewpoint.
Large HDAg has two important roles in the HDV life
cycle (for reviews, see Lazinski and Taylor, 1993; Lai,
1995 and references therein). This antigen can suppress
the replication of HDV RNA, but it is necessary for pack-
aging of HDV virion or empty virus-like particles (Chao et
al., 1990; Chang et al., 1991; Glenn and White, 1991; Ryu
FIG. 4. Effects of kinase inhibitors on the HDAg phosphorylation.
HuH-7 cells were transfected with the expression construct pECE-d
(dWT) (lanes 2–5) or pECE-D (DWT) (lanes 6–9) (20 mg), and at the
appropriate time, cells were treated with or without kinase inhibitor
(100 mM) and processed for in vivo 32Pi labeling (see Materials and
Methods). The HDAgs were immunoprecipitated from the cell lysates,
and half of the aliquots of the protein samples were analyzed by
SDS–PAGE and autoradiography. The other half of the aliquots of the
samples were subjected to Western blot analysis using a rabbit anti-
HDAg antibody (see Materials and Methods). The relative phosphory-
lation level was determined with a PhosphorImager. The relative posi-
tions for the large (L) or small (S) HDAgs are indicted. (Lane 1) Mock
without transfection. The molecular mass (in kDa) of the protein marker
is indicated.
FIG. 5. Effects of kinase inhibitors on the HDV RNA package. HuH-7 cells were cotransfected with equal amounts (20 mg each) of plasmid pECE-D,
pECE-d, pCDm2G, and pMTS (lanes 3–5). At day 2–3 post-transfection, cells were continuously treated with 100 mM DRB (lane 4) or H7 (lane 5) or
left untreated (lane 3). Total cellular RNA and the RNA of viral particles from day 3 post-transfected cells were prepared and analyzed by Northern
blotting using HDV strand-specific riboprobe (see Materials and Methods). The intracellular and secreted HDAgs were detected by Western blotting
using a human anti-HDAg antibody (see Materials and Methods). Samples for analysis has been prepared from the same amount of protein
(intracellular HDAg) or the same number of transfected cells (medium fraction). (Lane 1) Mock sample. (Lane 2) All experimental conditions are similar
to those for lanes 3–5 except that cells were cotransfected with equal amounts (20 mg each) of plasmid pCDm2G and pMTS but not HDAg-expressing
plasmid. All symbols are similar to those described in the legend for Figure 1.
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et al., 1992). Small HDAg can trans-activate the replica-
tion of HDV RNA (Kuo et al., 1989). Conceivably, the ratio
between large and small HDAgs in its infected cells
modulates the HDV life cycle. In the hepatocyte, the ratio
of large HDAg to small HDAg is ;0.1 (Bonino et al., 1986),
whereas in the virion, this ratio increases to 0.9 (Chang
et al., 1991). Interestingly, in this study, we found that the
ratio between these two HDAgs modulates the selection
of monomeric or dimeric HDV genomic RNA for assem-
bly. When this ratio in the transfected cells is approxi-
mately the same as that in liver cells, the packaged HDV
RNA is predominantly monomeric (Fig. 1B, lane 5). No-
tably, when the small HDAg is absent, the large HDAg
can package the monomeric and dimeric with apparently
equal efficiency. However, increasing the small HDAg
expression level, which may reflect the natural condition
for infected cells with active HDV replication, the pack-
aging efficiency of monomeric HDV RNA, but not the
dimeric one, caused significant enhancement. This ex-
plains why the monomeric form of HDV genomic RNA is
the predominant form present in the virion. The exact
mechanism for the preference of packaging of multi-
meric HDV RNA by the large HDAg, but not by the small
HDAg, is not yet known. Presumably, this may result from
the conformational difference between these two anti-
gens as pointed out previously (Hwang and Lai, 1993a,
1994), or it may reside on the attribute that the large
HDAg, but not the small HDAg, interacts with HBsAg
(Hwang and Lai, 1993b), which is an important factor in
the assembly of HDV RNA. Alternatively, this may result
from the selectivity of the small HDAg, but not the large
HDAg, for packaging of the monomeric, replicative form
of HDV genomic RNA. In fact, in transfected or infected
cells, most of the HDV RNA has been found to be asso-
ciated with small HDAg and not with large HDAg (Ryu et
al., 1993).
MATERIALS AND METHODS
Plasmids
The HDV sequence used in this study was derived
from plasmid pSVLD3 (Kuo et al., 1989). Plasmid
pCDm2G (Wang et al., 1994) and pCDm3G contain a
tandem dimer or trimer of the full-length, mutated HDV
cDNA in which a frameshift mutation in the HDAg ORF
destroys the production of both large and small HDAgs
and requires the functional small HDAg in trans for rep-
lication. Plasmid pGEM3L, which contains a ScaI/EcoRI
fragment (1.1 kb) of the HDV cDNA driven by the SP6 or
T7 phage promoter (Hu et al., 1996), was used for pro-
FIG. 6. Effects of serine-to-alanine substitution mutations on the assembly of HDV RNA by a small and/or large HDAg with HBsAg. HuH-7 cells were
cotransfected with the pCDm2G, pMTS, and the large or small HDAg-expressing construct pECE-D (DWT) or pECE-d (dWT) or its mutant derivatives
(20 mg each). Analyses of the HDV genomic RNA, as well as the HDAgs in these transfected cells after day 3 post-transfection, were followed
essentially as described in the legend for Figure 1. (M) Without transfection. The designations for HDV mutants are described in Materials and
Methods. D2, pECE-D2A; D123, pECE-D123A; D-210, pECE-D210A; d2, pECE-d2A; d123, pECE-d123A; D2/123, pECE-D2/123A; d2/123, pECE-d2/123A.
All symbols are similar to those described in the legend for Figure 1.
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duction of strand-specific probes by in vitro transcription.
Plasmid pMTS contains the major HBV surface antigen
(HBsAg) gene under the control of metallothionein pro-
moter (Sheu and Lo, 1992). This plasmid was used in the
transfection experiment to provide HBsAg (Yeh et al.,
1996). The expression plasmids for the wild-type and
mutated small HDAg defective in the CKII recognition
site (e.g., pECE-d, pECE-d2A, or pECE-d123A), as well as
the plasmids encoding the ORF of wild-type large HDAg
and its mutant derivatives defective in CKII or PKC rec-
ognition site (e.g., pECE-D, pECE-D2A, pECE-D123A, or
pECE-D210A), have been described previously (Yeh et al.,
1996). For construction of the HDAg-expressing plasmid
harboring substitution mutation at both serine-2 and
serine-123 residues, the 0.5-kb BglII/EcoRI fragment har-
boring the serine-2 mutation in HDAg ORF was excised
from pECE-d2A and used to replace the same fragment
on pECE-D123A or pECE-d123A. The resulting construct
pECE-D2/123A or pECE-d2/123A was also sequenced to
confirm their mutated residues.
Cell culture and transfection
DNA transfection experiments for this study were
adopted from the four-plasmid cotransfection system re-
ported by Wang et al. (1994). HuH-7 cells were seeded
(6 3 106 cells/15-cm-diameter dish) and cultured at 37°C
under 5% CO2 for 20 h in the Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum,
100 IU/ml penicillin, 100 mg/ml streptomycin, and 2 mM
l-glutamine. Cells were cotransfected with the appropri-
ate amounts of plasmid combinations (60–80 mg/15-cm-
diameter dish) by a calcium phosphate coprecipitation
method (Graham and van der Eb, 1973). When applica-
ble, the transfected cells were treated with 100 mM
kinase inhibitor DRB or H7 (Sigma Chemical, Poole,
Dorset, UK) during days 2–3 post-transfection. The cells
and media were harvested at day 3 post-transfection.
Isolation of HDV particles and characterization of
HDV particles by CsCl centrifugation
The secreted HDV viral particles were purified accord-
ing to a method described previously (Wu et al., 1991; Yeh
et al., 1996). When applicable, the HDV viral particles
were also purified by immunoprecipitation with mouse
anti-HBsAg monoclonal antibody (DAKO Japan, Kyoto,
Japan) from culture medium. The pellets recovered were
further processed for HDAg or HDV RNA analysis (Yeh et
al., 1996). For isopycnic centrifugation, the viral particles
prepared from a 35-ml sample of pooled medium of day
3 post-transfected HuH-7 cells by high speed centrifuga-
tion (Ti 55.2 rotor, 45,000 rpm centrifugation for 5 h) were
suspended in culture medium and subjected to centrif-
ugation in a CsCl gradient (average density, 1.205 g/ml;
final density, 1.122–1.422 g/ml) at 38,000 rpm in an SW41
rotor for 60 h. The gradients were fractionated into 0.5-ml
samples from the top, and aliquots of each fraction were
concentrated by centrifugation at 60,000 rpm for 2 hr in a
Beckman TLA100.2 rotor and then analyzed for various
viral markers. The density of each fraction was deter-
mined by the respective refractive index using a refrac-
tometer.
Northern and Western blotting
Total RNA from transfected HuH-7 cells or from viral
pellets was isolated as previously described (Yeh et al.,
1996). Northern blotting to detect HDV RNA and prepa-
ration of strand-specific riboprobe were essentially the
same as described previously (Yeh et al., 1996). The
HDAg was detected by the immunoblot using human
anti-HDAg sera as the primary antibody and horseradish
peroxidase-conjugated antibody as the secondary anti-
body. The blot was detected by enhanced chemilumines-
cence (ECL Kit, Amersham Japan, Tokyo, Japan).
Metabolic labeling of phosphorylated HDAg with 32Pi
and immunoprecipitation of the HDAg
For labeling the large and small HDAgs, HuH-7 cells
(7 3 106) were transfected with the expression plasmid
pECE-D or pECE-d (40 mg); after 32 h post-transfection,
cells were treated with or without kinase inhibitor (DRB,
H7, or HA1004; Sigma, 100 mM each) for 6 h and pro-
cessed for 32Pi labeling of the HDAg as described pre-
viously (Yeh et al., 1996). After 4 h of labeling, cells were
washed free of labeled medium and processed for im-
munoprecipitation with Protein A–Sepharose 4B-bound
human anti-HDAg antibody (Yeh et al., 1996). Bound pro-
teins were extracted from the Sepharose 4B beads, and
half of the aliquots of protein samples were analyzed by
SDS–PAGE and autoradiography, and the other half were
used for Western blot analysis and probed for HDAg
using rabbit anti-HDAg antibody and the ECL system for
detection.
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